AKT1 and Alzheimer disease: Previous studies have reported that PTEN antagonizing the activity of PI3K‐Akt signaling mediates Aβ‐induced neuronal growth impairment and synaptic dysfunction in AD (Jurado et al., 2010; Knafo et al., 2016).